NNE Pharmaplan company presentation

Preview:

DESCRIPTION

Our company presentation contains information about our company, our competences and our experiences.

Citation preview

Engineering for a healthier world

2

USA. A blood transfusion is vitalat some point in the treatment of

5 million patients each year.

CZECH REPUBLIC. Fresenius Hemocarehas just revamped their facility,

which manufactures blood bags.

Our company film

Where we come from1930s – Danish Novo and Nordisk Gentofte (later Novo Nordisk) employed the first engineers.

1974 - Pharmaplan was founded as part of the medical care group by Fresenius, Germany.

1991 - After functioning as in-house consultants at Novo Nordisk for years, NNE (Novo Nordisk Engineering A/S) demerged as an independent company.

2007 - Acquisition of Pharmaplan, a company similar to NNE in DNA.NNE Pharmaplan was founded.

With 80 years of experience we are passionate about our services to the pharma and biotech industries.

4

Recent awards 2004 IChemE: “Haden Freeman Award for Engineering Excellence”2005 ISPE Facility of the Year Award winner – Novo Nordisk’s NovoSeven (FVII) facility2008 ISPE Company of the Year winner2009 ISPE Facility of the Year Award winner – Facility Integration – hameln pharmaceuticals, Germany2009 ISPE Facility of the Year Award winner – Operational Excellence – R&D division of US biotech company, Switzerland2009 Emerson: “PlantWeb Excellence” for DeltaV application for Pronova BioPharma project (KalOmega)

Who we are

We are the leading consulting and engineering company in the complex field of pharma and biotech.

We count close to 1,700 professionals with project experience and knowledge related to pharma and biotech. More than 200 have hands-on development or production experience.

We executed 2,667 projects in 2010.

5

Our project execution and our staff

embody 10,000 years of

experience within pharma and biotech

Our future outlook

6

We want to be the leading international supplier of projects, engineering and consulting services to the pharma and biotech industries.

We advise organisations

such asISPE, PDA, ISO, FDA, SFDA, EMA

and WHO

Gunhild Diness

Our work split

7

We have a 91% customer satisfaction

rate. We are very proud of this fact.

The main part of our employees have a background in pharmaceutical production companies.

Closer to our customers

We employ close to 1,700 people at more than 25 locations in 11 countries around the world.

8

97% of our revenues

come from the pharma and biotech

industries

Global reach – local knowledge

9

Certifications:ISO 9001 Worldwide

ISO 14001OHSAS 18001

Optimal production processes

10

Company revenue

2010USD 279M EUR 197M

DEVELOP ESTABLISH IMPROVE

Projectdevelopment

Process & Productdevelopment

Investment projectCD / BD / DD / CON / C&Q

Optimisation, training, revamps,GAP analysis, operational support

Our services

11

Single use

With single-use technology you get maximum flexibility, fast change-over, no cross-contamination between productsand a lower investment cost.

12

Risk-based approach and Quality by Design

The answer to how you can avoid low-yield production or losing a batch.

13

Fast-track

In traffic, fast is not a virtue. In pharmaceutical engineering we believe it is. And we have pushed the limits many times.

14

Automation and IT

Automation & IT are key to obtaining competitive advantages by achieving faster, more efficient delivery at lower costs without compromising flexibility and quality.

15

Multiproduct revamps

Revamping your production allows you to safely increase production capacity while postponing large investments.

16

ASTM E2500 verification

ASTM E2500 is referred to as the validation of the future. How much money can it save you?

17

Personalised drugs and treatment

The general trend moves away from ‘blockbuster’ drugs to more personalised drugs, presenting completely new challenges to pharma companies.

18

Turnkey facilities

A turnkey solution will save you the trouble of dealing with multiple suppliers – you get everything from a single source.

19

Cost-effective operation and facilities

Cost-effective production is a must to survive in the highly competitive pharma market. Evolution calls for operational excellence, and we can help you get to the next level.

20

Recommended